Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent Advances in Schistosomiasis.

G. Richard Olds1, Srinivasan Dasarathy

  • 1Department of Medicine, MetroHealth Medical Center, Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, OH 44109-1998, USA. sdasarathy@hotmail.com.

Current Infectious Disease Reports
|February 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and Mediators.

Bioinformatics (Oxford, England)·2026
Same author

Urine Proteomic Profiling at Admission Reveals Complement Biomarkers Linked to Alcohol-Associated Liver Disease.

Alcohol, clinical & experimental research·2026
Same author

The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease.

Nature communications·2026
Same author

Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial.

Hepatology (Baltimore, Md.)·2026
Same author

Mean Arterial Pressure at Admission Predicts 28-day Mortality in Patients with Severe Alcohol-associated Hepatitis.

Clinical and translational gastroenterology·2026
Same author

SIRPα Cleavage Is Associated with Inflammatory Response, Corticosteroid Nonresponse, and Worse Prognosis in Clinical and Preclinical Models of Alcohol-Associated Hepatitis.

The American journal of pathology·2026

Schistosomiasis, a widespread parasitic disease, is now curable and preventable due to advances in diagnosis and treatment. Future vaccines are in development, but the disease

Area of Science:

  • Parasitic diseases
  • Tropical medicine
  • Public health

Background:

  • Schistosomiasis affects approximately 200 million people globally.
  • It is a significant parasitic disease with substantial health implications.

Purpose of the Study:

  • To review recent advancements in schistosomiasis research.
  • To highlight the curability and preventability of the disease.
  • To discuss future prospects, including vaccines and ongoing challenges.

Main Methods:

  • Literature review of schistosomiasis pathogenesis, diagnosis, therapeutics, and morbidity.
  • Analysis of current treatment strategies and drug development.
  • Examination of epidemiological trends and geographical spread.

Related Experiment Videos

Main Results:

  • Significant progress has been made in understanding schistosomiasis, leading to improved diagnostic tools and effective treatments.
  • Schistosomiasis-related pathology is largely reversible.
  • Several vaccine candidates are in early-stage clinical trials.

Conclusions:

  • Schistosomiasis is a treatable and preventable disease, with ongoing research focused on vaccine development.
  • Despite progress, the disease's range is expanding in some regions due to environmental and developmental factors.
  • Untreated schistosomiasis remains a major public health concern, particularly in sub-Saharan Africa.